Altium Announces Exclusive Partnership with Cytosurge for FluidFM Technology Distribution in North America!

Altium is excited to announce an exclusive partnership with Cytosurge to distribute FluidFM® technology across North America. This groundbreaking platform enables live-cell manipulation and non-destructive single-cell profiling, offering unparalleled insights into cellular dynamics, gene expression, and disease progression.

Together, we’re empowering researchers with innovative tools for advancing cancer research, drug resistance studies, and precision medicine. Stay tuned for updates as we revolutionize single-cell research!